IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 130 filers reported holding IVERIC BIO INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $316,687,000 | +89.3% | 8,050,000 | +4.9% | 4.30% | +73.2% |
| Q1 2023 | $167,281,500 | +15.8% | 7,675,000 | +13.7% | 2.48% | +14.8% |
| Q4 2022 | $144,517,500 | +36.5% | 6,750,000 | +14.4% | 2.16% | +10.5% |
| Q3 2022 | $105,846,000 | +54.5% | 5,900,000 | -17.1% | 1.96% | +44.5% |
| Q2 2022 | $68,494,000 | -43.9% | 7,120,000 | -1.8% | 1.35% | -39.3% |
| Q1 2022 | $122,018,000 | +0.7% | 7,250,000 | 0.0% | 2.23% | +8.0% |
| Q4 2021 | $121,220,000 | +5.1% | 7,250,000 | +2.1% | 2.06% | +13.9% |
| Q3 2021 | $115,304,000 | +184.4% | 7,100,000 | +10.5% | 1.81% | +156.9% |
| Q2 2021 | $40,542,000 | -9.5% | 6,425,000 | -11.4% | 0.70% | -8.9% |
| Q1 2021 | $44,805,000 | -10.6% | 7,250,000 | 0.0% | 0.77% | -10.3% |
| Q4 2020 | $50,098,000 | +22.5% | 7,250,000 | 0.0% | 0.86% | +48.5% |
| Q3 2020 | $40,890,000 | +12.9% | 7,250,000 | +2.1% | 0.58% | -18.9% |
| Q2 2020 | $36,210,000 | – | 7,100,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |